pharmaceutical
Blog
The Role of Patents in the Pharmaceutical Sector

The Role of Patents in the Pharmaceutical Sector 

The pharmaceutical sector is a critical part of the healthcare industry, responsible for developing life-saving drugs and innovative treatments. In this highly competitive and research-driven field, patents play a pivotal role. They are not just legal documents but also essential tools that influence various aspects of the pharmaceutical industry. In this blog post, we will explore the multifaceted role of patents in the pharmaceutical sector.  More…

Blog
Revolutionising Chemotherapy: A Breakthrough DNA Repair Test Takes the Guesswork out of Treatment

Revolutionising Chemotherapy: A Breakthrough DNA Repair Test Takes the Guesswork out of Treatment

 

Chemotherapy has long been a critical tool in the fight against cancer, but its effectiveness can be hindered by the unpredictable way each patient’s body responds to treatment. However, a ground-breaking DNA repair test developed by researchers at Brunel University London promises to revolutionise the field of oncology by taking the “hit-and-miss” out of chemotherapy. The test is called DiNArep, and it has already been granted patents in the UK, US, EU, and Japan. In this blog post, we delve into the details of this remarkable advancement and explore the potential it holds for transforming cancer treatment.

More…

Blog
Pfizer signs deal allowing generics to produce COVID pill

Pfizer signs deal allowing generics to produce COVID pill

On the 16th of November, Pfizer announced a deal with international public health group Medicines Patent Pool (MPP) that will allow generic drug manufacturers to produce and supply its experimental antiviral COVID-19 pill. The licensing agreement will authorise the MPP to grant sub-licenses to qualified drug companies in 95 low and middle-income countries, giving residents access to affordable life-saving treatment.  More…

Brazilian
Blog
Brazilian pharmaceutical patents
no longer subject to ANVISA’s
prior approval

Brazilian pharmaceutical patents no longer subject to ANVISA’s prior approval

Back in March this year, the Brazilian Federal Government issued the Provisional Measure No. 1,040/2021. Their aim is to improve the business environment in Brazil and elevate the country’s position in the World Bank’s “Doing Business” ranking. President Bolsonaro has now sanctioned this measure and the corresponding Law No 14.195 entered into force on August 26th, 2021. More…

Copyright © 2022 Minesoft | Privacy policy